physicochemical Aspects of Pulmonary Surfactant

Fetal and Neonatal Physiology: Third Edition

Volumn 2-2, Issue , 2003, Pages 1014-1034

  Possmayer, Fred ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84911114062     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9654-6.50104-1     Document Type: Chapter

References (261)

1. Jobe A.H. Pulmonary surfactant therapy. N Engl J Med 1993, 328(12):861-868.
2. Soll R.F., Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome (Cochrane Review). The Cochrane Library 2002, 2002.
3. Soll R.F. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants (Cochrane Review). The Cochrane Library 2002, 2002.
4. Curley A.E., Halliday H.L. The present status of exogenous surfactant for the newborn. Early Hum Dev 2001, 61(2):67-83.
5. Jobe A.H., Ikegami M. Lung development and function in preterm infants in the surfactant treatment era. Annu Rev Physiol 2000, 62:825-846.
6. McCabe A.J., et al. Surfactant: a review for pediatric surgeons. J Pediatr Surg 2000, 35(12):1687-1700.
7. Robertson B., Halliday H.L. Principles of surfactant replacement. Biochim Biophys Acta 1998, 1408(2-3):346-361.
8. Wiswell T.E. Expanded uses of surfactant therapy. Clin Perinatol 2001, 28(3):695-711.
9. Frerking I., et al. Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med 2001, 27(11):1699-1717.
10. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999, 13(6):1455-1476.
11. Gunther A., et al. Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res 2001, 2(6):353-364.
12. Lesur O., et al. Acute respiratory distress syndrome: 30 years later. Can Respir J 1999, 6(1):71-86.
13. Lewis J.F., Veldhuizen R.A. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 2003, 65:613-642.
14. Lewis J.F., Jobe A.H. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993, 147:218-233.
15. Spragg R.G. Surfactant replacement therapy. Clin Chest Med 2000, 21(3):531-541. ix.
16. Akino T. Lipid components of the surfactant system. In Pulmonary Surfactant: from Molecular Biology to Clinical Practice 1992, 19-31. Elsevier, Amsterdam. B. Robertson (Ed.).
17. Batenburg J.J., Haagsman H.P. The lipids of pulmonary surfactant: dynamics and interactions with proteins. Prog Lipid Res 1998, 37(4):235-276.
18. Cockshutt A.M., Possmayer F. Metabolism of surfactant lipids and proteins in the developing lung. In Pulmonary Surfactant: From Molecular Biology to Clinical Practice 1992, 339-377. Elsevier, Amsterdam. B. Robertson (Ed.).
19. Van Golde L.M., et al. The pulmonary surfactant system: biochemical aspects and functional significance. Physiol Rev 1988, 68(2):374-455.
20. Veldhuizen R., et al. The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1998, 1408:90-108.
21. Crouch E., Wright J.R. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001, 63:521-554.
22. Haagsman H.P., Diemel R.V. Surfactant-associated proteins: functions and structural variation. Comp Biochem Physiol A Mol Integr Physiol 2001, 129(1):91-108.
23. Hawgood S., Poulain F.R. The pulmonary collectins and surfactant metabolism. Annu Rev Physiol 2001, 63:495-519.
24. Weaver T.E., Conkright J.J. Function of surfactant proteins B and C. Annu Rev Physiol 2001, 63:555-578.
25. Kahn M.C., et al. Phosphatidylcholine molecular species of calf lung surfactant. Am J Physiol 1995, 269(5 Pt 1):L567-L573.
26. Postle A.D., et al. A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comp Biochem Physiol A Mol Integr Physiol 2001, 129(1):65-73.
27. McCormack F.X. Structure, processing and properties of surfactant protein A. Biochim Biophys Acta 1998, 1408(2-3):109-131.
28. Palaniyar N., et al. Domains of surfactant protein A that affect protein oligomerization, lipid structure and surface tension. Comp Biochem Physiol A Mol Integr Physiol 2001, 129(1):109-127.
29. LeVine A.M., Whitsett J.A. Pulmonary collectins and innate host defense of the lung. Microbes Infect 2001, 3(2):161-166.
30. Hakansson K., Reid K.B. Collectin structure: a review. Protein Sci 2000, 9(9):1607-1617.
31. Vaandrager A.B., van Golde L.M. Lung surfactant proteins A and D in innate immune defense. Biol Neonate 2000, 77(Suppl 1):9-13.
32. McCormack F.X., Whitsett J.A. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002, 109(6):707-712.
33. Clark H.W., et al. Collectins and innate immunity in the lung. Microbes Infect 2000, 2(3):273-278.
34. Crouch E., et al. Collectins and pulmonary innate immunity. Immunol Rev 2000, 173:52-65.
35. Hawgood S., et al. Structure and properties of surfactant protein B. Biochim Biophys Acta 1998, 1408(2-3):150-160.
36. Lawson P.R., Reid K.B. The roles of surfactant proteins A and D in innate immunity. Immunol Rev 2000, 173:66-78.
37. Reid K.B. Interactions of surfactant protein D with pathogens, allergens and phagocytes. Biochim Biophys Acta 1998, 1408(2-3):290-295.
38. Tino M.J., Wright J.R. Interactions of surfactant protein A with epithelial cells and phagocytes. Biochim Biophys Acta 1998, 1408(2-3):241-263.
39. Walther F.J., et al. Surfactant protein B and C analogues. Mol Genet Metab 2000, 71(1-2):342-351.
40. Cole F.S., et al. Genetic disorders of neonatal respiratory function. Pediatr Res 2001, 50(2):157-162.
41. Weaver T.E., Beck D.C. Use of knockout mice to study surfactant protein structure and function. Biol Neonate 76 Suppl 1999, 1:15-18.
42. Johansson J. Structure and properties of surfactant protein C. Biochim Biophys Acta 1998, 1408(2-3):161-172.
43. Whitsett J.A., Baatz J.E. Hydrophobic surfactant proteins SP-B and SP-C: molecular biology, structure, and function. In Pulmonary Surfactant: From Molecular Biology to Clinical Practice 1992, 685-703. Elsevier, Amsterdam. B. Robertson (Ed.).
44. Jobe A., Ikegami M. Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 1987, 136(5):1256-1275.
45. Jobe A.H. Surfactant treatment. In Fetal and Neonatal Physiology 1997, Vol. 2:1321-1335. W.B. Saunders Company, Philadelphia. R.A. Polin, W.W. Fox (Eds.).
46. Bernhard W., et al. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium. Am J Respir Crit Care Med 2000, 162(4 Pt 1):1524-1533.
47. Fujiwara T., Robertson B. Pharmacology of exogenous surfactant. In Pulmonary Surfactant: From Molecular Biology to Clinical Practice 1992, 561-592. Elsevier, Amsterdam. B. Robertson (Ed.).
48. Notter R.H., et al. Component-specific surface and physiological activity in bovine-derived lung surfactants. Chem Phys Lipids 2002, 114(1):21-34.
49. Notter R.H., Wang Z. Pulmonary surfactant: physical chemistry, physiology, and replacement. Rev Chem Engineering 1997, 13(4):1-118.
50. Clark R.H., et al. A comparison of the outcomes of neonates treated with two different natural surfactants. J Pediatr 2001, 139(6):828-831.
51. Robertson B., et al. Synthetic surfactants to treat neonatal lung disease. Mol Med Today 2000, 6(3):119-124.
52. Nilsson G., et al. Synthetic peptide-containing surfactants-evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to polyleucyl substitution [In Process Citation]. Eur J Biochem 1998, 255(1):116-124.
53. Tabor B., et al. Rapid clearance of surfactant-associated palmitic acid from the lungs of developing and adult animals. Pediatr Res 1990, 27(3):268-273.
54. Jobe A.H., Ikegami M. Surfactant metabolism. Clin Perinatol 1993, 20(4):683-696.
55. Jobe A.H. Which surfactant for treatment of respiratory-distress syndrome. Lancet 2000, 355(9213):1380-1381.
56. Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2001, 2(1):33-46.
57. Mulugeta S., et al. Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J Biol Chem 2002, 277(25):22147-22155.
58. van Golde L.M.G., et al. The pulmonary surfactant system. NIPS 1994, 9:13-20.
59. Williams M.C. Morphologic aspects of the surfactant system. In Pulmonary Surfactant: From Molecular Biology to Clinical Practice 1992, 87-107. Elsevier, Amsterdam. B. Robertson (Ed.).
60. Wright J.R., Dobbs L.G. Regulation of pulmonary surfactant secretion and clearance. Annu Rev Physiol 1991, 53:395-414.
61. Wright J.R. Clearance and recycling of pulmonary surfactant. Am J Physiol 1990, 259(2 Pt 1):L1-12.
62. Farrell P.M., et al. Relationships among surfactant fraction lipids, proteins and biophysical properties in the developing rat lung. Biochim Biophys Acta 1990, 1044(1):84-90.
63. Froh D., et al. Lamellar bodies of cultured human fetal lung: content of surfactant protein A (SP-A), surface film formation and structural transformation in vitro. Biochim Biophys Acta 1990, 1052(1):78-89.
64. Oosterlaken-Dijksterhuis M.A., et al. Surfactant protein composition of lamellar bodies isolated from rat lung. Biochem J 1991, 274(Pt 1):115-119.
65. Ikegami M., Jobe A.H. Surfactant metabolism. Semin Perinatol 1993, 17(4):233-240.
66. Beckmann H.-J., Dierichs R. Extramembranous particles and structural variations of tubular myelin figures in rat lung surfactant. J Ultrastr Res 1984, 86:57-66.
67. Nag K., et al. Correlated atomic force and transmission electron microscopy of nanotubular structures in pulmonary surfactant. J Struct Biol 1999, 126(1):1-15.
68. Voorhout W.F., et al. Surfactant protein A is localized at the corners of the pulmonary tubular myelin lattice. J Histochem Cytochem 1991, 39:1331-1336.
69. Benson B.J., et al. Role of apoprotein and calcium ions in surfactant function. Exp Lung Res 1984, 6(3-4):223-236.
70. Gross N.J. Extracellular metabolism of pulmonary surfactant: the role of a new serine protease. Annu Rev Physiol 1995, 57:135-150.
71. Lewis J.F., Veldhuizen R.A. Factors influencing efficacy of exogenous surfactant in acute lung injury. Biol Neonate 1995, 67(Suppl 1):48-60.
72. Baritussio A., et al. SP-A, SP-B, and SP-C in surfactant subtypes around birth: reexamination of alveolar life cycle of surfactant. Am J Physiol 1994, 266(4 Pt 1):L436-L447.
73. Putman E., et al. Pulmonary surfactant subtype metabolism is altered after short-term ozone exposure. Toxicol Appl Pharmacol 1995, 134(1):132-138.
74. Putz G., et al. Surface activity of rabbit pulmonary surfactant subfractions at different concentrations in a captive bubble. J Appl Physiol 1994, 77(2):597-605.
75. Veldhuizen R.A., et al. Surfactant-associated protein A is important for maintaining surfactant large-aggregate forms during surface-area cycling. Biochem J 1996, 313(Pt 3):835-840.
76. von Neergaard K. Neue Auffassungen aber einen Grundbegriff der Atemmechanik. Die Retraktionskraft der Lunge, abhangig von der Oberflachenspannung in den Alveolen. Z Gesammte Exp Med 1929, 66:373-394.
77. Clements J.A. Surface phenomena in relation to pulmonary function. Physiologist 1962, 5(1):11-28.
78. Radford E.P. Recent studies of mechanical properties of mammalian lungs. In Tissue Elasticity 1957, 177-190. American Physiological Society, Bethesda, MD. J.W. Remington (Ed.).
79. Clements J. Surface tension of lung extracts. Proc Soc Exp Biol Med 1957, 95:170-172.
80. Pattle R. Properties, function and origin of the alveolar lining layer. Nature 1955, 175:1125-1126.
81. Adam N.K. The Physics and Chemistry of Surfaces 1941, Oxford University Press, Oxford, U.K.
82. Adamson A.W. Physical Chemistry of Surfaces 1982, John Wiley & Sons, New York.
83. Defay R., Prigogine I. Surface Tension and Adsorption 1966, John Wiley & Sons, New York.
84. Gaines G.L. Insoluble Monolayers at Liquid-Gas Interfaces 1966, Interscience Publishers, John Wiley & Sons, New York.
85. Notter R.H. Lung Surfactants. Basic Science and Clinical Applications 2000, Marcel Dekker, Inc.
86. Bois A.G., Albon N. Equilibrium spreading of L-alpha-dipalmitoyl lecithin below the main bilayer transition temperature: can it be measured?. J Colloid Interface Sci 1985, 104:579-582.
87. Lawrie G.A., et al. Spreading properties of dimyristoyl phosphatidylcholine at the air/water interface. Chem Phys Lipids 1996, 79(1):1-8.
88. Philips M.C., Hauser H. Spreading of solid glycerides and phospholipids at the air/water interface. J Colloid Interface Sci 1974, 49:31-39.
89. Vilallonga F. Surface of L-alpha-diphalmitoyl lecithin at the air-water interface. Biochim Biophys Acta 1968, 163(3):290-300.
90. Meban C. Effect of lipids and other substances on the adsorption of dipalmitoyl phosphatidyl choline. Pediatr Res 1981, 15:1029-1031.
91. Notter R.H., et al. Path dependence of adsorption behavior of mixtures containing dipalmitoyl phosphatidylcholine. Pediatr Res 1982, 16(7):515-519.
92. Yu S.-H., Possmayer F. Effect of pulmonary surfactant protein B (SP-B) and calcium on phospholipid adsorption and squeeze-out of phosphatidylglycerol from binary phospholipid monolayers containing dipalmitoylphosphatidylcholine. Biochim Biophys Acta 1992, 1126:26-34.
93. Yu S.H., Possmayer F. Adsorption, compression and stability of surface films from natural, lipid extract and reconstituted pulmonary surfactants. Biochim Biophys Acta 1993, 1167(3):264-271.
94. Hawco M.W., et al. Exclusion of fluid lipid during compression of monolayers of mixtures of dipalmitoylphosphatidylcholine with some other phosphatidylcholines. Biochim Biophys Acta 1981, 646(1):185-187.
95. Hawco M.W., et al. Lipid fluidity in lung surfactant: monolayers of saturated and unsaturated lecithins. J Appl Physiol 1981, 51(2):509-515.
96. Keough K.M.W. Physical chemical properties of some mixtures of lipids and their potential for use in exogenous surfactant. Prog Respir Res 1984, 18:257-262.
97. Tchoreloff P., et al. A structural study of interfacial phospholipid and lung surfactant layers by transmission electron microscopy after Blodgett sampling: influence of surface pressure and temperature. Chem Phys Lipids 1991, 59(2):151-165.
98. Denicourt N., et al. The liquid condensed diffusional transition of dipalmitoylphosphoglycerocholine in monolayers. Biophys Chem 1989, 33(1):63-70.
99. Denicourt N., et al. The main transition of dipalmitoylphosphatidylcholine monolayers: A liquid expanded to solid condensed high order transformation. Biophys Chem 1994, 49:153-162.
100. Albrecht O., et al. Polymorphism of phospholipid monolayers. Le Journal de Physique 1978, 39:301-313.
101. Trauble H., et al. Respiration-a critical phenomenon? Lipid phase transitions in the lung alveolar surfactant. Naturwissenschaften 1974, 61(8):344-354.
102. Kaganer V.M., et al. Structure and phase transitions in Langmuir monolayers. Rev Modern Phys 1999, 71:779-819.
103. Brumm T., et al. Conformational changes of the lecithin headgroup in monolayers at the air/water interface. Eur Biophys J 1994, 23:289-295.
104. Discher B.M., et al. Lateral phase separation in interfacial films of pulmonary surfactant. Biophys J 1996, 71(5):2583-2590.
105. Discher B.M., et al. Phase separation in monolayers of pulmonary surfactant phospholipids at the air-water interface: composition and structure. Biophys J 1999, 77(4):2051-2061.
106. Nag K., et al. Phase transitions in films of lung surfactant at the air-water interface. Biophys J 1998, 74(6):2983-2995.
107. Clements J.A. Functions of the alveolar lining. Am Rev Respir Dis 1977, 115(6 Pt 2):67-71.
108. Engstrom P.C., et al. Surfactant replacement attenuates the increase in alveolar permeability in hyperoxia. J Appl Physiol 1989, 67(2):688-693.
109. Bangham A.D. Lung surfactant: how it does and does not work. Lung 1987, 165(1):17-25.
110. Keough K.M.W. Physical chemistry of pulmonary surfactant in the terminal air spaces. In Pulmonary Surfactant: From Molecular Biology to Clinical Practice 1992, 109-164. Elsevier, Amsterdam. B. Robertson (Ed.).
111. Goerke J., Clements J.A. Alveolar surface tension and lung surfactant. In Handbook of Physiology, Section 3: The Respiratory System 1986, Vol. III, Part 1:247-261. American Physiological Society, Bethesda, MD. A.P. Fishman (Ed.).
112. Perez-Gil J., Keough K.M.W. Interfacial properties of surfactant proteins. Biochim Biophys Acta 1998, 1408(2-3):203-217.
113. Watkins J.C. The surface properties of pure phospholipid to those of lung extracts. Biochim Biophys Acta 1968, 152:293-306.
114. Egberts J., et al. Minimal surface tension, squeeze-out and transition temperatures of binary mixtures of dipalmitoylphosphatidylcholine and unsaturated phospholipids. Biochim Biophys Acta 1989, 1002(1):109-113.
115. Goerke J., Gonzales J. Temperature dependence of dipalmitoyl phosphatidylcholine monolayer stability. J Appl Physiol 1981, 51(5):1108-1114.
116. Goerke J. Pulmonary surfactant: Functions and molecular composition. Biochim Biophys Acta 1998, 1408(2-3):79-89.
117. Hildebran J.N., et al. Pulmonary surface film stability and composition. J Appl Physiol 1979, 47(3):604-611.
118. Bachofen H., et al. Disturbance of alveolar lining layer: effects on alveolar microstructure. J Appl Physiol 1994, 76(5):1983-1992.
119. Scharch S., et al. Surface activity in situ, in vivo, and in the captive bubble surfactometer. Comp Biochem Physiol A Mol Integr Physiol 2001, 129(1):195-207.
120. Wilson T.A., Bachofen H. A model for mechanical structure of the alveolar duct. J Appl Physiol 1982, 52(4):1064-1070.
121. Bachofen H., Scharch S. Alveolar surface forces and lung architecture. Comp Biochem Physiol A Mol Integr Physiol 2001, 129(1):183-193.
122. Bachofen H., et al. Relations among alveolar surface tension, surface area, volume, and recoil pressure. J Appl Physiol 1987, 62(5):1878-1887.
123. Scharch S., et al. Direct determination of surface tension in the lung. Proc Natl Acad Sci USA 1976, 73(12):4698-4702.
124. Scharch S., et al. Direct determination of volume- and time-dependence of alveolar surface tension in excised lungs. Proc Natl Acad Sci USA 1978, 75(7):3417-3421.
125. Scharch S. Surface tension at low lung volumes: dependence on time and alveolar size. Respir Physiol 1982, 48:339-355.
126. Jobe A.H., Ikegami M. Biology of surfactant. Clin Perinatol 2001, 28(3):655-669. vii-viii.
127. Metcalfe I.L., et al. Lung expansion and survival in rabbit neonates treated with surfactant extract. J Appl Physiol 1982, 53(4):838-843.
128. Yamada T., et al. Effects of surfactant protein-A on surfactant function in preterm ventilated rabbits. Am Rev Respir Dis 1990, 142(4):754-757.
129. Possmayer F., et al. Surface activity in vitro: role of surfactant proteins. Comp Biochem Physiol A Mol Integr Physiol 2001, 129(1):209-220.
130. Kelly E., et al. Compliance of the respiratory system in newborn infants pre- and postsurfactant replacement therapy. Pediatr Pulmonol 1993, 15(4):225-230.
131. Milner A.D. How does exogenous surfactant work?. Arch Dis Child 1993, 68(3 Spec No):253-254.
132. Veldhuizen E.J., Haagsman H.P. Role of pulmonary surfactant components in surface film formation and dynamics. Biochim Biophys Acta 2000, 1467(2):255-270.
133. Scharch S., et al. A captive bubble method reproduces the in situ behavior of lung surfactant monolayers. J Appl Physiol 1989, 67(6):2389-2396.
134. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977, 43(2):198-203.
135. Enhorning G. Pulmonary surfactant function studied with the pulsating bubble surfactometer (PBS) and the capillary surfactometer (CS). Comp Biochem Physiol A Mol Integr Physiol 2001, 129(1):221-226.
136. Hall S.B., et al. Approximations in the measurement of surface tension on the oscillating bubble surfactometer. J Appl Physiol 1993, 75(1):468-477.
137. Putz G., et al. Comparison of captive and pulsating bubble surfactometers with use of lung surfactants. J Appl Physiol 1994, 76(4):1425-1431.
138. Scharch S., et al. Formation and structure of surface films: captive bubble surfactometry. Biochim Biophys Acta 1998, 1408(2-3):180-202.
139. Schoel W.M., et al. The captive bubble method for the evaluation of pulmonary surfactant: surface tension, area, and volume calculations. Biochim Biophys Acta 1994, 1200(3):281-290.
140. Lee S., et al. Equilibrium and dynamic interfacial tension measurements at microscopic interfaces using a micropipet technique. 2. Dynamics of phospholipid monolayer formation and equilibrium tensions at the water-air interface. Langmuir 2001, 17:5544-5550.
141. Schwarz G., Zhang J. Chain length dependence of lipid partitioning between the air/water interface and its subphase: thermodynamic and structural implications. Chem Phys Lipids 2001, 110(1):35-45.
142. Hope M.J., et al. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review). Mol Membr Biol 1998, 15(1):1-14.
143. Scharch S., et al. Surface activity of lipid extract surfactant in relation to film area compression and collapse. J Appl Physiol 1994, 77(2):974-986.
144. Notter R.H., et al. Comparative adsorption of natural lung surfactant, extracted phospholipids, and artificial phospholipid mixtures to the air-water interface. Chem Phys Lipids 1983, 33(1):67-80.
145. Notter R.H. Surface chemistry of pulmonary surfactant: The role of individual components. In Pulmonary Surfactant 1984, 17-65. Elsevier Science Publishers, Amsterdam. B. Robertson (Ed.).
146. Obladen M., et al. Surfactant substitution. Eur J Pediatr 1979, 131(4):219-228.
147. Skita V., et al. Bilayer characteristics of a diether phosphonolipid analog of the major lung surfactant glycerophospholipid dipalmitoyl phosphatidylcholine. J Lipid Res 1995, 36(5):1116-1127.
148. Brown D.A., London E. Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes?. Biochem Biophys Res Commun 1997, 240(1):1-7.
149. London E., Brown D.A. Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta 2000, 1508(1-2):182-195.
150. Anderson R.G., Jacobson K. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 2002, 296(5574):1821-1825.
151. Nanjundan M., Possmayer F. Pulmonary phosphatidic acid phosphatase and lipid phosphate phosphohydrolase (PAP/LPP). Am J Physiol Lung Cell Mol Physiol 2003, 284:L1-L23.
152. Doyle I.R., et al. Composition of alveolar surfactant changes with training in humans. Respirology 2000, 5(3):211-220.
153. Orgeig S., et al. Effect of hyperpnea on the cholesterol to disaturated phospholipid ratio in alveolar surfactant of rats. Exp Lung Res 1995, 21(1):157-174.
154. Orgeig S., Daniels C.B. The roles of cholesterol in pulmonary surfactant: insights from comparative and evolutionary studies. Comp Biochem Physiol A Mol Integr Physiol 2001, 129(1):75-89.
155. Holm B.A., et al. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 1988, 49(1-2):49-55.
156. Tanaka Y., et al. Development of synthetic lung surfactants. J Lipid Res 1986, 27:475-485.
157. Perkins W.R., et al. Role of lipid polymorphism in pulmonary surfactant. Science 1996, 273(5273):330-332.
158. Yu S.-H., et al. Artificial pulmonary surfactant: Potential role for hexagonal H-II phase in the formation of a surface active monolayer. Biochim Biophys Acta 1984, 776:37-47.
159. Piknova B., et al. Pulmonary surfactant: phase behavior and function. Curr Opin Struct Biol 2002, 12(4):487-494.
160. Fujiwara T., et al. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980, 1(8159):55-59.
161. Metcalfe I.L., et al. Pulmonary surfactant-associated proteins: their role in the expression of surface activity. J Appl Physiol 1980, 49(1):34-41.
162. Suzuki Y., et al. Experimental studies on the pulmonary surfactant: reconstitution of surface-active material. J Lipid Res 1982, 23:53-61.
163. Notter R.H., Shapiro D.L. Lung surfactants for replacement therapy: biochemical, biophysical, and clinical aspects. Clin Perinatol 1987, 14(3):433-479.
164. Suzuki Y. Effect of protein, cholesterol, and phosphatidylglycerol on the surface activity of the lipid-protein complex reconstituted from pig pulmonary surfactant. J Lipid Res 1982, 23(1):62-69.
165. Takahashi A., Fujiwara T. Proteolipid in bovine lung surfactant: its role in surfactant function. Biochem Biophys Res Commun 1986, 135(2):527-532.
166. Hawgood S., et al. Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption. Proc Natl Acad Sci USA 1987, 84(1):66-70.
167. Yu S.H., Possmayer F. Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactant. Biochem J 1986, 236(1):85-89.
168. Yu S.H., Possmayer F. Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant. Biochim Biophys Acta 1988, 961(3):337-350.
169. Yu S.H., Possmayer F. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures. Biochim Biophys Acta 1990, 1046(3):233-241.
170. Wang Z., et al. Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant. J Lipid Res 1996, 37(4):790-798.
171. Wang Z., et al. Differential activity and lack of synergy of lung surfactant proteins SP-B and SP-C in interactions with phospholipids. J Lipid Res 1996, 37(8):1749-1760.
172. Possmayer F., Yu S.-H. Role of the low molecular weight proteins in pulmonary surfactant. Prog Respir Res 1990, 25:54-63.
173. Chung J., et al. Effect of surfactant-associated protein-A (SP-A) on the activity of lipid extract surfactant. Biochim Biophys Acta 1989, 1002(3):348-358.
174. Cockshutt A.M., et al. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 1990, 29(36):8424-8429.
175. Rodriguez Capote K., et al. Surfactant protein interactions with neutral and acidic phospholipid films. Am J Physiol Lung Cell Mol Physiol 2001, 281(1):L231-L242.
176. Zaltash S., et al. Pulmonary surfactant protein B: a structural model and a functional analogue. Biochim Biophys Acta 2000, 1466(1-2):179-186.
177. Zaltash S., et al. Membrane activity of (Cys48Ser) lung surfactant protein B increases with dimerisation. Biol Chem 2001, 382(6):933-939.
178. Veldhuizen E.J., et al. Dimeric N-terminal segment of human surfactant protein B (dSP-B(1-25)) has enhanced surface properties compared to monomeric SP-B(1-25). Biophys J 2000, 79(1):377-384.
179. Williams M.C., et al. Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C. Am J Respir Cell Mol Biol 1991, 5(1):41-50.
180. Brouillette C.G., et al. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim Biophys Acta 2001, 1531(1-2):4-46.
181. Poulain F.R., et al. Kinetics of phospholipid membrane fusion induced by surfactant apoproteins A and B. Biochim Biophys Acta 1996, 1278(2):169-175.
182. Duzgunes N., Bentz J. Fluorescence assays for membrane fusion. In Spectroscopic Membrane Probes 1988, Vol 1:117-159. CRC Press, Boca Raton, FL. L. Loew (Ed.).
183. Suzuki Y., et al. Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am Rev Respir Dis 1989, 140:75-81.
184. Qanbar R., Possmayer F. On the surface activity of surfactant- associated protein C (SP-C): effects of palmitoylation and pH. Biochim Biophys Acta 1995, 1255(3):251-259.
185. Qanbar R., et al. Role of the palmitoylation of surfactant-associated protein C in surfactant film formation and stability. Am J Physiol 1996, 271(4 Pt 1):L572-L580.
186. Wang Z., et al. Acylation of pulmonary surfactant protein-C is required for its optimal surface active interactions with phospholipids. J Biol Chem 1996, 271(32):19104-19109.
187. Gustafsson M., et al. The palmitoyl groups of lung surfactant protein C reduce unfolding into a fibrillogenic intermediate. J Mol Biol 2001, 310(4):937-950.
188. Szyperski T., et al. Pulmonary surfactant-associated polypeptide C in a mixed organic solvent transforms from a monomeric alpha-helical state into insoluble beta-sheet aggregates. Protein Sci 1998, 7(12):2533-2540.
189. Ross M., et al. Kinetics of phospholipid insertion into monolayers containing the lung surfactant proteins SP-B or SP-C. Eur Biophys J 2002, 31(1):52-61.
190. Creuwels L.A., et al. Neutralization of the positive charges of surfactant protein C. Effects on structure and function. J Biol Chem 1995, 270(27):16225-16229.
191. Creuwels L.A., et al. The pulmonary surfactant system: biochemical and clinical aspects. Lung 1997, 175(1):1-39.
192. Oosterlaken-Dijksterhuis M.A., et al. Characterization of lipid insertion into monomolecular layers mediated by lung surfactant proteins SP-B and SP-C. Biochemistry 1991, 30(45):10965-10971.
193. Oosterlaken-Dijksterhuis M.A., et al. Interaction of lipid vesicles with monomolecular layers containing lung surfactant proteins SP-B or SP-C. Biochemistry 1991, 30:8276-8281.
194. Creuwels L.A., et al. Effect of acylation on structure and function of surfactant protein C at the air-liquid interface. J Biol Chem 1993, 268(35):26752-26758.
195. Nag K., et al. SP-B refining of pulmonary surfactant phospholipid films. Am J Physiol 1999, 277(6 Pt 1):L1179-L1189.
196. Wang Z., et al. Dynamic surface activity of films of lung surfactant phospholipids, hydrophobic proteins, and neutral lipids. J Lipid Res 1995, 36(6):1283-1293.
197. Takamoto D.Y., et al. Interaction of lung surfactant proteins with anionic phospholipids. Biophys J 2001, 81(1):153-169.
198. Veldhuizen E.J., et al. Effect of the hydrophobic surfactant proteins on the surface activity of spread films in the captive bubble surfactometer. Chem Phys Lipids 2001, 110(1):47-55.
199. Veldhuizen E.J., et al. The role of surfactant proteins in DPPC enrichment of surface films. Biophys J 2000, 79(6):3164-3171.
200. Scharch S., et al. The surface-associated surfactant reservoir in the alveolar lining. Biol Neonate 1995, 67:61-76.
201. Bangham A.D., et al. The physical properties of an effective lung surfactant. Biochim Biophys Acta 1979, 573(3):552-556.
202. Zasadzinski J.A., et al. The physics and physiology of lung surfactants. Curr Opin Colloid Interface Sci 2001, 6:506-513.
203. Sen A., et al. Localization of lipid exchange sites between bulk lung surfactants and surface monolayer: freeze fracture study. J Colloid Interface Sci 1988, 126:355-360.
204. Yu S.-H., Possmayer F. Effect of pulmonary surfactant protein SP-A on adsorption of cholesterol and dipalmitoylphosphatidylcholine into the monolayer. Biophys J 2001, 80:545A.
205. Yu S.-H., Possmayer F. Lipid compositional analysis of pulmonary surfactant monolayers and monolayer-associated reservoirs. J Lipid Res 2003, 44:621-629.
206. Yu S.H., Possmayer F. Interaction of pulmonary surfactant protein A with dipalmitoylphosphatidylcholine and cholesterol at the air/water interface. J Lipid Res 1998, 39(3):555-568.
207. Yu S.H., et al. Interactions of pulmonary surfactant protein SP-A with monolayers of dipalmitoylphosphatidylcholine and cholesterol: roles of SP-A domains. J Lipid Res 1999, 40(5):920-929.
208. Scharch S., et al. Pulmonary SP-A enhances adsorption and appears to induce surface sorting of lipid extract surfactant. Am J Physiol 1992, 263(2 Pt 1):L210-L218.
209. Amrein M., et al. A scanning force- and fluorescence light microscopy study of the structure and function of a model pulmonary surfactant. Eur Biophys J 1997, 26(5):349-357.
210. Lipp M.M., et al. Coexistence of buckled and flat monolayers. Phys Rev Lett 1998, 81:1650-1653.
211. Bourdos N., et al. Analysis of lung surfactant model systems with time-of-flight secondary ion mass spectrometry. Biophys J 2000, 79(1):357-369.
212. Ding J., et al. Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability. Biophys J 2001, 80(5):2262-2272.
213. Warriner H.E., et al. A concentration-dependent mechanism by which serum albumin inactivates replacement lung surfactants. Biophys J 2002, 82(2):835-842.
214. Kramer A., et al. Distribution of the surfactant-associated protein C within a lung surfactant model film investigated by near-field optical microscopy. Biophys J 2000, 78(1):458-465.
215. Diemel R.V., et al. Multilayer formation upon compression of surfactant monolayers depends on protein concentration as well as lipid composition: an atomic force microscopy study. J Biol Chem 2002, 277(24):21179-21188.
216. von Nahmen A., et al. The phase behavior of lipid monolayers containing pulmonary surfactant protein C studied by fluorescence light microscopy. Eur Biophys J 1997, 26:359-369.
217. Post A., et al. Pulmonary surfactant protein C containing lipid films at the air-water interface as a model for the surface of lung alveoli. Mol Membr Biol 1995, 12:93-99.
218. Krol S., et al. Formation of three-dimensional protein-lipid aggregates in monolayer films induced by surfactant protein B. Biophys J 2000, 79(2):904-918.
219. Discher B.M., et al. Neutral lipids induce critical behavior in interfacial monolayers of pulmonary surfactant. Biochemistry 1999, 38(1):374-383.
220. Piknova B., et al. Discrepancy between phase behavior of lung surfactant phospholipids and the classical model of surfactant function. Biophys J 2001, 81(4):2172-2180.
221. Crane J.M., Hall S.B. Rapid compression transforms interfacial monolayers of pulmonary surfactant. Biophys J 2001, 80(4):1863-1872.
222. Laderas T.G., et al. Persistent metastability of rapidly compressed monolayers at the air-water interface. Biophys J 2002, 82:152A.
223. Moses D., et al. Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol 1991, 164(2):477-481.
224. Herting E., et al. Resistance of different surfactant preparations to inactivation by meconium. Pediatr Res 2001, 50(1):44-49.
225. Enhorning G., et al. Phospholipases introduced into the hypophase affect the surfactant film outlining a bubble. J Appl Physiol 1992, 73(3):941-945.
226. Kobayashi T., et al. Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 1991, 29(4 Pt 1):353-356.
227. Holm B.A., et al. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 1991, 71(1):317-321.
228. Cockshutt A.M., Possmayer F. Lysophosphatidylcholine sensitizes lipid extracts of pulmonary surfactant to inhibition by serum proteins. Biochim Biophys Acta 1991, 1086(1):63-71.
229. Seeger W., et al. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 1985, 58(2):326-338.
230. Holm B.A. Surfactant inactivation in adult respiratory distress syndrome. In Pulmonary Surfactant: From Molecular Biology to Clinical Practice 1992, 665-684. Elsevier, Amsterdam. B. Robertson (Ed.).
231. Hall S.B., et al. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis 1992, 145(1):24-30.
232. Venkitaraman A.R., et al. Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins. Chem Phys Lipids 1991, 57(1):49-57.
233. Seeger W., et al. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993, 6(7):971-977.
234. Friedrich W., et al. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins. Eur J Med Res 2000, 5(7):277-282.
235. Mbagwu N., et al. Sensitivity of synthetic surfactants to albumin inhibition in preterm rabbits. Mol Genet Metab 1999, 66(1):40-48.
236. Venkitaraman A.R., et al. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A. Chem Phys Lipids 1990, 56(2-3):185-194.
237. Yukitake K., et al. Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo. Pediatr Res 1995, 37(1):21-25.
238. Strayer D.S., et al. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo. Am J Respir Crit Care Med 1996, 153(3):1116-1122.
239. Elhalwagi B.M., et al. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Am J Respir Cell Mol Biol 1999, 21(3):380-387.
240. Ikegami M., et al. The collagen-like region of surfactant protein A (SP-A) is required for correction of surfactant structural and functional defects in the SP-A null mouse. J Biol Chem 2001, 276(42):38542-38548.
241. Holm B.A., et al. Multiple mechanisms of lung surfactant inhibition. Pediatr Res 1999, 46(1):85-93.
242. Cockshutt A.M., et al. The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins. Biochim Biophys Acta 1991, 1085(2):248-256.
243. McEachren T.M., Keough K.M. Phosphocholine reverses inhibition of pulmonary surfactant adsorption caused by C-reactive protein. Am J Physiol 1995, 269(4 Pt 1):L492-L497.
244. Seeger W., et al. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity [published erratum appears in Am J Respir Cell Mol Biol 1993 Oct;9(4):following 462]. Am J Respir Cell Mol Biol 1993, 9(2):213-220.
245. Gunther A., et al. Clot-embedded natural surfactant: kinetics of fibrinolysis and surface activity. Am J Physiol 1994, 267(5 Pt 1):L618-L624.
246. Gunther A., et al. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity. Am J Respir Cell Mol Biol 1999, 21(6):738-745.
247. Tashiro K., et al. Dextran reduces surfactant inhibition by meconium. Acta Paediatr 2000, 89(12):1439-1445.
248. Taeusch H.W., et al. Nonionic polymers reverse inactivation of surfactant by meconium and other substances. Am J Respir Crit Care Med 1999, 159(5 Pt 1):1391-1395.
249. Campbell H., et al. Polyethylene glycol (PEG) attenuates exogenous surfactant in lung-injured adult rabbits. Am J Respir Crit Care Med 2002, 165(4):475-480.
250. Lu K.W., et al. Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries. Am J Respir Crit Care Med 2001, 164(8 Pt 1):1531-1536.
251. Gilliard N., et al. Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension properties. J Clin Invest 1994, 93(6):2608-2615.
252. Bridges J.P., et al. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J Biol Chem 2000, 275(49):38848-38855.
253. Cifuentes J., et al. Interaction of surfactant mixtures with reactive oxygen and nitrogen species. J Appl Physiol 1995, 78(5):1800-1805.
254. Zhu S., et al. Carbon dioxide enhances nitration of surfactant protein A by activated alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2000, 278(5):L1025-L1031.
255. Zhu S., et al. Increased levels of nitrate and surfactant protein a nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 2001, 163(1):166-172.
256. Rodriguez Capote K., Possmayer F. SP-A restores the surface activity of oxidized pulmonary surfactant. Biophys J 2002, 82:2554. 2Pos.
257. Jobe A.H. Techniques for administering surfactant. In Surfactant Therapy for Lung Disease 1995, 309-324. Marcel Dekker, New York. B. Robertson, H.W. Taeusch (Eds.).
258. Johansson J., et al. Artificial surfactants based on analogues of SP-B and SP-C. Pediatr Pathol Mol Med 2001, 20(6):501-518.
259. Robertson B., et al. Prospects for a new synthetic surfactant. Acta Biomed Ateneo Parmense 2000, 71(Suppl 1):409-412.
260. Possmayer F., et al. Pulmonary surfactant. Can J Biochem Cell Biol 1984, 62(11):1121-1133.
261. Goerke J. Lung surfactant. Biochim Biophys Acta 1974, 344(3-4):241-261.